Showing results (1401-1410 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|April 10, 2014
Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillationTorbjørn Wisløff, Gunhild Hagen, Marianne Klemp
Pharmacoeconomics|May 14, 2014
Cost-effectiveness analyses of targeted oral anti-cancer drugs: a systematic reviewFabrice Smieliauskas, Chun-Ru Chien, Chan Shen, et al.
Pharmacoeconomics|May 9, 2014
A review of the economics of treating Clostridium difficile infectionKari A Mergenhagen, Amy L Wojciechowski, Joseph A Paladino
Pharmacoeconomics|April 17, 2012
Pharmacoeconomics of bisphosphonates for skeletal-related event prevention in metastatic non-breast solid tumoursJohn A Carter, Avani D Joshi, Satyin Kaura, et al.
Pharmacoeconomics|September 19, 2014
Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European projectAriel Beresniak, Antonieta Medina-Lara, Jean Paul Auray, et al.
Pharmacoeconomics|March 21, 2013
Bivalirudin for the treatment of ST-segment elevation myocardial infarction: a NICE single technology appraisalE L Simpson, P Fitzgerald, P Evans, et al.
Pharmacoeconomics|December 3, 2013
Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-MedicareFadia T Shaya, Ian M Breunig, Brian Seal, et al.
Pharmacoeconomics|December 3, 2013
The value of a QALY: individual willingness to pay for health gains under riskAna Bobinac, Job van Exel, Frans F H Rutten, et al.
Pageof 336